We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

BIO-RAD LABORATORIES

Provides full range of instrumentation, reagent kits, software and quality control systems to clinical laboratories. ... read more Featured Products: More products

Download Mobile App




Droplet Digital PCR Rapidly Detects Alpha-Thalassemia Variants

By LabMedica International staff writers
Posted on 24 Aug 2016
Print article
Image: The QX100 Droplet digital PCR reader (Photo courtesy of Bio-Rad).
Image: The QX100 Droplet digital PCR reader (Photo courtesy of Bio-Rad).
Alpha (α)-thalassemia is a highly prevalent genetic disease worldwide and it is characterized by various degrees of alpha globin chain deficit caused by either deletional or non-deletional mutations although the former are more common.

Recently, there have been more reported cases of rare α-thalassemia mutations due to the advancement of molecular techniques involved in thalassemia detections. Therefore, it is essential to develop a new method, which allows the detection of different α-thalassemia mutations including the rare ones simultaneously and accurately.

Scientists at the University Putra Malaysia (Serdang, Malaysia) designed an assay for the detection of triplications, common and rare deletional α-thalassemia using droplet digital PCR (ddPCR). Eleven archived DNA samples with known genotypes and one DNA sample with heterozygous deletion spanning from HS-40 region to alpha1 globin region were used in the study.

Four copy number variations (CNV) assays were carried out in duplications for each sample, which includes the upstream alpha globin regulatory element HS- 40, Hemoglobin, alpha 2 (HBA2), HBA3.7 and HBA1 genes. A total of 20 µL of each polymerase chain reaction (PCR) mixture was loaded into a sample well of a DG8TM Cartridge for QX100 Droplet Generator (Bio-Rad Laboratories, Hercules, CA, USA), followed by 70 µL of droplet generation oil into the oil wells. After the thermal cycling process, the sealed 96-well plate was placed in the Bio-Rad QX100 Droplet Digital Reader.

The team found that found that the use of ddPCR is convenient as it allows direct quantification without the requirement of a calibration curve unlike quantitative PCR. They showed that showed that ddPCR is accurate and precise in the detection of alpha thalassemia deletions and triplications based on the gene dosages using absolute quantification. Twelve samples with different α-thalassemia deletions at different regions located at HS-40 to HBA1 and triplications of α-globin genes were detected accurately. The investigators also showed that ddPCR saves time with less turnaround time and minimize the labor work required as compared to other techniques. The study was published in the August 2016 issue of the International Journal of Laboratory Hematology.

Related Links:
University Putra Malaysia
Bio-Rad Laboratories
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Liquid biopsy could detect and monitor aggressive small cell lung cancer (Photo courtesy of Shutterstock)

Blood-Based Test Detects and Monitors Aggressive Small Cell Lung Cancer

Small cell lung cancer (SCLC) is a highly aggressive type of cancer known for its ability to metastasize. The behavior of tumors is largely governed by which genes are turned on, or transcribed, irrespective... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.